Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

88.85 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
72 73 Next >
News headline image
U.S. Manufacturing Picture Is Looking Brighter Than Europe's Right Now ↗
(Tuesday Market Open) Global jitters over U.S. House Speaker Nancy Pelosi’s expected visit to Taiwan dominated premarket trading with major U.S. equities indexes moving mildly lower before the open.... 
Via Benzinga
News headline image
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak ↗
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care... 
Via Benzinga
News headline image
5 Value Stocks In The Healthcare Sector ↗
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
News headline image
Analyst Ratings for BioNTech ↗
Analysts have provided the following ratings for BioNTech (NASDAQ:BNTX) within the last quarter: 
Via Benzinga
News headline image
Is The Energy Ready To Rebound? ↗
(Monday Market Open) Equity index futures turned a bit negative to start a new week and month, as investors are still digesting last week’s data with the S&P 500® index (SPX) near June highs. 
Via Benzinga
News headline image
Pfizer Ticks Higher As Covid Vaccine, Pill Carry Its Second-Quarter Beat ↗
The company projects strong sales of Comirnaty and Paxlovid in 2022. 
Via Investor's Business Daily
News headline image
Is Moderna's Cheaper Valuation A Buying Signal?
Moderna is one of the least expensive companies in the S&P 500 in terms of valuation. In this article, we'll examine other aspects of the company. 
Via MarketBeat
Topics Stocks
News headline image
Pfizer/BioNTech Start Ohase 2 Trial For COVID-19 Vaccine Against Omicron Subvariant ↗
 
Via Benzinga
News headline image
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
From BioNTech SE
Via GlobeNewswire
News headline image
BioNTech, Pfizer File For Clearance Over COVID-19 Vaccine Patent Dispute With CureVac ↗
 
Via Benzinga
News headline image
Overview Of Value Stocks In The Healthcare Sector ↗
What is a Value Stock? 
Via Benzinga
News headline image
WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years ↗
 
Via Benzinga
News headline image
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why BioNTech Is Trading Higher Today Following A Stock Upgrade From SVB Securities Analyst ↗
SVB Securities, a division of SVB Financial Group (NASDAQ: SIVB), believes BioNTech SE – ADR (NASDAQ: BNTX) stock is trading below the most negative scenario for the COVID-19 vaccine mar 
Via Benzinga
News headline image
Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
Via Benzinga
News headline image
Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On Upgrade ↗
BioNTech won an upgrade Wednesday. Here's what one analyst expects to drive growth. 
Via Investor's Business Daily
News headline image
AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, In Expert Review ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Benzinga Before The Bell: Most Effective Covid-19 Vaccine, Google's Hiring Slowdown, Panasonic's New EV Battery And Other Top Financial Stories Wednesday, July 13 ↗
CNBC Bankrupt Crypto Firm Three Arrows Capital’s Assets Frozen By New York Judge 
Via Benzinga
News headline image
Amazon.com To $145? Here's The Biggest Price Target Changes For Wednesday ↗
SVB Leerink cut BioNTech SE (NASDAQ: BNTX) price target from $253 to $223. BioNTech shares rose 2.1% to $164.77 in pre-market trading. 
Via Benzinga
News headline image
Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out ↗
 
Via Benzinga
News headline image
U.S. Stock Futures Higher; All Eyes On Inflation Data ↗
Pre-open movers 
Via Benzinga
News headline image
The Good News For Moderna's Covid Shot Barely Moved Its Stock ↗
Moderna stock reacted minimally to positive results for its updated Covid booster. 
Via Investor's Business Daily
News headline image
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says ↗
Novavax is hoping to launch an updated Covid booster shot. 
Via Investor's Business Daily
News headline image
Pharma Rally Continues As Pfizer, Amgen Look To Break Out, Pulling Rivals With Them ↗
Four pharmaceutical stocks, including three biotech movers, are making big moves. 
Via Investor's Business Daily
News headline image
What Is Going on With Novavax (NVAX) Stock Today? ↗
NVAX stock is down more than 8% today even after a surprise announcement of a vaccine deal with the U.S. government. 
Via InvestorPlace
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... 
Via Benzinga
News headline image
US Government Signs COVID-19 Vaccine Pact With Novavax, With FDA Decision Still Pending ↗
Novavax Inc (NASDAQ: NVAX) has announced an agreement with the U.S. 
Via Benzinga
News headline image
Novavax, Moderna, BioNTech Surge To 3-Month High As Omicron Boosters Loom ↗
Moderna and BioNTech also surged to a three-month high Friday. 
Via Investor's Business Daily
News headline image
European Regulator Willing To Use COVID-19 Boosters Targeting Omicron Variants ↗
At a press briefing, the European Medicines Agency (EMA) said it is open to using updated COVID-19 vaccines that target older omicron variants this Fall, amid a rise in cases due to new om 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
72 73 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.